Trial Profile
A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Acronyms LOTUSDI
- Sponsors Allergan
- 04 Jan 2014 New trial record